Medacta Group SA
SIX:MOVE

Watchlist Manager

Medacta Group SA

SIX:MOVE

Watchlist

Dividends

Price: 110.8 CHF 2.21% Market Closed

Market Cap: 2.2B CHF

Have any thoughts about
Medacta Group SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 110.8 CHF

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

MOVE Alert

Medacta Group SA

110.8

+2.4 (+2.21%)

52 Week Range	108.4 134
Price Target

We'll email you a reminder when the closing price reaches CHF.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Medacta Group SA

What unique competitive advantages
does Medacta Group SA hold over its rivals?

What risks and challenges
does Medacta Group SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Medacta Group SA.

What unique competitive advantages
does Medacta Group SA hold over its rivals?

What risks and challenges
does Medacta Group SA face in the near future?

Has there been any significant insider trading activity
in Medacta Group SA recently?

Summarize the latest earnings call
of Medacta Group SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medacta Group SA.

Provide P/S
for Medacta Group SA.

Provide P/E
for Medacta Group SA.

Provide P/OCF
for Medacta Group SA.

Provide P/FCFE
for Medacta Group SA.

Provide P/B
for Medacta Group SA.

Provide EV/S
for Medacta Group SA.

Provide EV/GP
for Medacta Group SA.

Provide EV/EBITDA
for Medacta Group SA.

Provide EV/EBIT
for Medacta Group SA.

Provide EV/OCF
for Medacta Group SA.

Provide EV/FCFF
for Medacta Group SA.

Provide EV/IC
for Medacta Group SA.

Show me price targets
for Medacta Group SA made by professional analysts.

What are the Revenue projections
for Medacta Group SA?

How accurate were the past Revenue estimates
for Medacta Group SA?

What are the Net Income projections
for Medacta Group SA?

How accurate were the past Net Income estimates
for Medacta Group SA?

What are the EPS projections
for Medacta Group SA?

How accurate were the past EPS estimates
for Medacta Group SA?

What are the EBIT projections
for Medacta Group SA?

How accurate were the past EBIT estimates
for Medacta Group SA?

Compare the revenue forecasts
for Medacta Group SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medacta Group SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medacta Group SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medacta Group SA compared to its peers.

Compare the P/E ratios
of Medacta Group SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Medacta Group SA with its peers.

Analyze the financial leverage
of Medacta Group SA compared to its main competitors.

Show all profitability ratios
for Medacta Group SA.

Provide ROE
for Medacta Group SA.

Provide ROA
for Medacta Group SA.

Provide ROIC
for Medacta Group SA.

Provide ROCE
for Medacta Group SA.

Provide Gross Margin
for Medacta Group SA.

Provide Operating Margin
for Medacta Group SA.

Provide Net Margin
for Medacta Group SA.

Provide FCF Margin
for Medacta Group SA.

Show all solvency ratios
for Medacta Group SA.

Provide D/E Ratio
for Medacta Group SA.

Provide D/A Ratio
for Medacta Group SA.

Provide Interest Coverage Ratio
for Medacta Group SA.

Provide Altman Z-Score Ratio
for Medacta Group SA.

Provide Quick Ratio
for Medacta Group SA.

Provide Current Ratio
for Medacta Group SA.

Provide Cash Ratio
for Medacta Group SA.

What is the historical Revenue growth
over the last 5 years for Medacta Group SA?

What is the historical Net Income growth
over the last 5 years for Medacta Group SA?

What is the current Free Cash Flow
of Medacta Group SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medacta Group SA.

EV/EBITDA
Enterprise Value to EBITDA

17.9

Current

19.9

Median

12.8

Industry

Lower than median

Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

17.9

Enterprise Value

2.3B CHF

EBITDA

140.3m EUR

All Countries

Forward Multiples

		Market Cap	EV/EBITDA
CH	Medacta Group SA SIX:MOVE	2.2B CHF	17.9
US	Abbott Laboratories NYSE:ABT	204.9B USD	20.7
US	Intuitive Surgical Inc NASDAQ:ISRG	195.2B USD	74.3
US	Stryker Corp NYSE:SYK	146.7B USD	26.5
US	Boston Scientific Corp NYSE:BSX	132.6B USD	33.9
IE	Medtronic PLC NYSE:MDT	110.6B USD	14.7
US	Becton Dickinson and Co NYSE:BDX	64.7B USD	15.6
DE	Siemens Healthineers AG XETRA:SHL	55.6B EUR	17.1
CN	Shenzhen Mindray Bio-Medical Electronics Co Ltd SZSE:300760	319.2B CNY	22.1
US	Edwards Lifesciences Corp NYSE:EW	41.6B USD	22.1
US	GE Healthcare Technologies Inc NASDAQ:GEHC	37.7B USD	14

			EBITDA Growth
CH	Medacta Group SA SIX:MOVE	Average EV/EBITDA: 25.4 17.9	55%
US	Abbott Laboratories NYSE:ABT	20.7	32%
US	Intuitive Surgical Inc NASDAQ:ISRG	74.3	112%
US	Stryker Corp NYSE:SYK	26.5	42%
US	Boston Scientific Corp NYSE:BSX	33.9	76%
IE	Medtronic PLC NYSE:MDT	14.7	27%
US	Becton Dickinson and Co NYSE:BDX	15.6	35%
DE	Siemens Healthineers AG XETRA:SHL	17.1	53%
CN	Shenzhen Mindray Bio-Medical Electronics Co Ltd SZSE:300760	22.1	70%
US	Edwards Lifesciences Corp NYSE:EW	22.1	10%
US	GE Healthcare Technologies Inc NASDAQ:GEHC	14	41%

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

2-Years Forward

EV/EBITDA

13.8

3-Years Forward

EV/EBITDA

12.1

Medacta Group SA
SIX:MOVE

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Medacta Group SA SIX:MOVE

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Medacta Group SA
SIX:MOVE

EV/EBITDA
Enterprise Value to EBITDA